Fluticasone prop 50 MCG spray 16GM
Ended Awarded Last action
- Contract number
- SPE2DR26F9NV1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,110
Award facts
- Contract value 100% obligated
- $3,110.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,110.40 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate 50 MCG Spray (16 grams) on January 30, 2026, with an ultimate completion date of February 2, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems through the DLA Medical Supply Chain. This particular delivery order for fluticasone propionate—a corticosteroid used in respiratory treatments—represents one of many routine pharmaceutical deliveries the company executes under its master indefinite delivery contract, demonstrating the company's capability to efficiently fulfill government requirements for essential medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9NV1?
SPE2DR26F9NV1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9NV1 worth?
The government has obligated $3,110 on SPE2DR26F9NV1.
Is contract SPE2DR26F9NV1 an order under another contract?
Yes. SPE2DR26F9NV1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NV1 competed?
The extent of competition for SPE2DR26F9NV1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award